Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes the study of AZD0120 in adults with refractory systemic lupus erythematosus, spanning Phase 1 and Phase 2, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• AZD0120

Snippet

Sponsor: AstraZeneca | Conditions: Lupus Erythematosus, Systemic | Phase 1, Phase 2 | Status: RECRUITING